Faculty profile

Laurel Thorlacius

Back to faculty

Associate ProfessorDepartment of Pathology and Laboratory MedicineUniversity of Manitoba

Laurel Thorlacius

Associate Professor

Department of Pathology and Laboratory Medicine

Max Rady College of Medicine

University of Manitoba

Winnipeg, Manitoba, Canada

Supervision signals

Professors usually supervise graduate students in their department's programs.
8 publications in the last five years, latest in 2025.

These signals come from public records, including federal and provincial funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

1,218

Citations

134

Collaborators

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

University Profile

Search on Google Scholar

Search on ResearchGate

OpenAlex

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their University of Manitoba profile.

Latest papers

Choosing Wisely Canada recommendations for clinical biochemistry: test ordering for sustainable and high-quality patient care.
Clinical biochemistry · 2025
Assessing Analytical Performance and Correct Classification for Cardiac Troponin Deltas Across Diagnostic Pathways Used for Myocardial Infarction
Diagnostics · 2025
Imprecision of high-sensitivity cardiac troponin assays at the female 99th-percentile
Clinical Biochemistry · 2024

All 12 publications

12 publications.

Choosing Wisely Canada recommendations for clinical biochemistry: test ordering for sustainable and high-quality patient care.

Beriault DR, Chen Y, Yip P, Blasutig I, Bhayana V, Rutledge AC, Parker M, Kinniburgh D, Thomas D, Colbourne P, Langman L, Delaney SR, Bennett M, Oleschuk C, Huang Y, Rodriguez-Capote K, Hauff K, Konforte D, Kalra J, Bouhtiauy I, El Hassan MA, Elnenaei M, Thorlacius L, Venner AA, Randell EW, Sohn KY, Leung F, Taher J, Lou A, Arnoldo S, CSCC Utilization Special Interest Group

Clinical biochemistry20257 citationsOpen Access

DOI: 10.1016/j.clinbiochem.2025.110951 PMID: 40409393

Assessing Analytical Performance and Correct Classification for Cardiac Troponin Deltas Across Diagnostic Pathways Used for Myocardial Infarction

Kavsak PA, Sharif S, Demian WL, Choi W-S, Belley-Cote EP, Taher J, Shea JL, Blank DW, Knauer M, Thorlacius L

Diagnostics20252 citationsOpen Access

DOI: 10.3390/diagnostics15131652

Imprecision of high-sensitivity cardiac troponin assays at the female 99th-percentile

Kavsak PA, Clark L, Arnoldo S, Lou A, Shea JL, Eintracht S, Lyon AW, Bhayana V, Thorlacius L, Raizman JE

Clinical Biochemistry202410 citationsOpen Access

DOI: 10.1016/j.clinbiochem.2024.110731

Assay Precision and Risk of Misclassification at Rule-Out Cutoffs for High-Sensitivity Cardiac Troponin

Kavsak PA, Mills NL, Clark L, Ko DT, Sharif S, Chen-Tournoux A, Friedman SM, Belley-Cote EP, Worster A, Cox J

Canadian Journal of Cardiology20248 citationsOpen Access

DOI: 10.1016/j.cjca.2024.05.007

New solutions to old problems: A practical approach to identify samples with intravenous fluid contamination in clinical laboratories

Ashley M. Newbigging, Natalie M. Landry, Miranda M. Brun, Dustin T. Proctor, Michelle B. Parker, Carmen Zimmer, Laurel Thorlacius, Joshua E. Raizman, Albert K.Y. Tsui

Clinical Biochemistry20245 citations

DOI: 10.1016/j.clinbiochem.2024.110763 PMID: 38615787

Analytic Result Variation for High-Sensitivity Cardiac Troponin: Interpretation and Consequences

Kavsak PA, Clark L, Arnoldo S, Lou A, Shea JL, Eintracht S, Lyon AW, Bhayana V, Thorlacius L, Raizman JE

Canadian Journal of Cardiology202329 citationsOpen Access

DOI: 10.1016/j.cjca.2023.04.013 PMID: W4366754135

Establishing quality indicators for point of care glucose testing: recommendations from the Canadian Society for Clinical Chemists Point of Care Testing and Quality Indicators Special Interest Groups.

Shaw JLV, Arnoldo S, Beach L, Bouhtiauy I, Brinc D, Brun M, Collier C, Kostantin E, Fung AWS, Füzéry AK, Huang Y, Kaur S, Knauer M, Labrecque L, Leung F, Shea JL, Thakur V, Thorlacius L, Venner AA, Yip PM, De Guire V

Clinical chemistry and laboratory medicine20238 citationsOpen Access

DOI: 10.1515/cclm-2023-0147 PMID: 37043622

Strategies used in managing conversations about prostate-specific antigen (PSA) testing among family physicians (FPs): a qualitative study.

Driedger SM, Kirby S, Maier R, Süss R, Thorlacius L, Saranchuk JW, Bohm E, Singer A

BMJ open20233 citationsOpen Access

DOI: 10.1136/bmjopen-2023-073415 PMID: 37117002

Evaluation of commercial SARS-CoV-2 serological assays in Canadian public health laboratories.

Stein DR, Osiowy C, Gretchen A, Thorlacius L, Fudge D, Lang A, Sekirov I, Morshed M, Levett PN, Tran V, Kus JV, Gubbay J, Mohan V, Charlton C, Kanji JN, Tipples G, Serhir B, Therrien C, Roger M, Jiao L, Zahariadis G, Needle R, Gilbert L, Desnoyers G, Garceau R, Bouhtiauy I, Longtin J, El-Gabalawy N, Dibernardo A, Lindsay LR, Drebot M, Canadian Public Health Laboratory Network (CPHLN) Serology Task Force

Diagnostic microbiology and infectious disease202117 citationsOpen Access

DOI: 10.1016/j.diagmicrobio.2021.115412 PMID: 34425450

The Fracture Risk Assessment Tool (FRAX®) predicts fracture risk in patients with chronic kidney disease

Whitlock RH, Leslie WD, Shaw J, Rigatto C, Thorlacius L, Komenda P, Collister D, Kanis JA, Tangri N

Kidney International201989 citationsOpen Access

DOI: 10.1016/j.kint.2018.09.022

Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.

Something wrong or missing on this profile? Suggest a correction

Laurel Thorlacius

Research

Latest papers

Choosing Wisely Canada recommendations for clinical biochemistry: test ordering for sustainable and high-quality patient care.

Assessing Analytical Performance and Correct Classification for Cardiac Troponin Deltas Across Diagnostic Pathways Used for Myocardial Infarction

Imprecision of high-sensitivity cardiac troponin assays at the female 99th-percentile

Assay Precision and Risk of Misclassification at Rule-Out Cutoffs for High-Sensitivity Cardiac Troponin

New solutions to old problems: A practical approach to identify samples with intravenous fluid contamination in clinical laboratories

Analytic Result Variation for High-Sensitivity Cardiac Troponin: Interpretation and Consequences

Establishing quality indicators for point of care glucose testing: recommendations from the Canadian Society for Clinical Chemists Point of Care Testing and Quality Indicators Special Interest Groups.

Strategies used in managing conversations about prostate-specific antigen (PSA) testing among family physicians (FPs): a qualitative study.

Evaluation of commercial SARS-CoV-2 serological assays in Canadian public health laboratories.

The Fracture Risk Assessment Tool (FRAX®) predicts fracture risk in patients with chronic kidney disease

Frequent collaborators

Yun Huang

Paul Yip

Saranya Arnoldo

Jennifer Taher

Daniel Beriault

Peter Kavsak

Andrew Worster

Karin Humphries

Venkatesh Thiruganasambandamoorthy

Emilie Belley-Cote

Albert Tsui

Frank Scheuermeyer

Sameer Sharif

Ronald Booth

Christopher McCudden

Felix Leung

Susanna Mak

Neville Suskin

Philip Devereaux

Eric Bohm

Dennis Ko

Michael Knauer

Curtis Oleschuk

Brian Steinhart

Amanda Lang

Barry Hoffman

Sarah McDonald

Hertzel Chaim Gerstein